FDA targets early September for approving Pfizer's Covid-19 vaccine
Published
Officials have recently accelerated their work and now hope to finalize approval in a matter of weeks.
Full ArticlePublished
Officials have recently accelerated their work and now hope to finalize approval in a matter of weeks.
Full ArticleDr. Scott Gottliebe, the former head of the Food and Drug Administration, said that the agency could soon authorize Pfizer's..
Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine that it developed in collaboration with German BioNTech is expected to receive full FDA..